In particular, CD4+ T cells contribute to the initiation of the immune response in MS patients, while CD8+ T cells, are believed to be the major lymphocytes found in active MS lesions, which have been identified as potential major contributors to MS pathology [8]. Here, CD8A is linked to myeloid sarcoma.